BIO-key International, Inc.
BKYI
$0.7761
$0.02713.62%
NASDAQ
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 87.93% | -47.68% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 87.93% | -47.68% | |||
| Cost of Revenue | 77.32% | -12.45% | |||
| Gross Profit | 91.09% | -53.28% | |||
| SG&A Expenses | -17.20% | 8.91% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.51% | 3.91% | |||
| Operating Income | 64.91% | -225.03% | |||
| Income Before Tax | 55.67% | -226.67% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 55.67% | -226.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 55.67% | -226.67% | |||
| EBIT | 64.91% | -225.03% | |||
| EBITDA | 69.11% | -281.70% | |||
| EPS Basic | 60.99% | -217.28% | |||
| Normalized Basic EPS | 60.99% | -217.38% | |||
| EPS Diluted | 60.99% | -217.28% | |||
| Normalized Diluted EPS | 60.99% | -217.38% | |||
| Average Basic Shares Outstanding | 13.63% | 2.95% | |||
| Average Diluted Shares Outstanding | 13.63% | 2.95% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||